Alyaa A. Ramadan

880 total citations
24 papers, 685 citations indexed

About

Alyaa A. Ramadan is a scholar working on Pharmaceutical Science, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Alyaa A. Ramadan has authored 24 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 6 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Alyaa A. Ramadan's work include Advancements in Transdermal Drug Delivery (7 papers), Trace Elements in Health (3 papers) and Advanced Drug Delivery Systems (3 papers). Alyaa A. Ramadan is often cited by papers focused on Advancements in Transdermal Drug Delivery (7 papers), Trace Elements in Health (3 papers) and Advanced Drug Delivery Systems (3 papers). Alyaa A. Ramadan collaborates with scholars based in Egypt, Switzerland and France. Alyaa A. Ramadan's co-authors include Labiba K. El‐Khordagui, Nawal M. Khalafallah, Riham M. El‐Moslemany, Noha Nafee, Maha M. Eissa, Mervat Z. El‐Azzouni, Doaa A. Abdelmonsif, Amal H. El‐Kamel, Patrick Saulnier and Eglal I. Amer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Alyaa A. Ramadan

22 papers receiving 672 citations

Peers

Alyaa A. Ramadan
Alyaa A. Ramadan
Citations per year, relative to Alyaa A. Ramadan Alyaa A. Ramadan (= 1×) peers Riham M. El‐Moslemany

Countries citing papers authored by Alyaa A. Ramadan

Since Specialization
Citations

This map shows the geographic impact of Alyaa A. Ramadan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alyaa A. Ramadan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alyaa A. Ramadan more than expected).

Fields of papers citing papers by Alyaa A. Ramadan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alyaa A. Ramadan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alyaa A. Ramadan. The network helps show where Alyaa A. Ramadan may publish in the future.

Co-authorship network of co-authors of Alyaa A. Ramadan

This figure shows the co-authorship network connecting the top 25 collaborators of Alyaa A. Ramadan. A scholar is included among the top collaborators of Alyaa A. Ramadan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alyaa A. Ramadan. Alyaa A. Ramadan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abouelfetouh, Alaa, et al.. (2025). Antibacterial and anti-virulence activity of eco-friendly resveratrol-loaded lipid nanocapsules against methicillin-resistant staphylococcus aureus. Scientific Reports. 15(1). 14677–14677. 1 indexed citations
2.
El‐Moslemany, Riham M., et al.. (2025). Lactoferrin functionalized bovine serum albumin nanoparticles for synergistic chemo-gene therapy of lung cancer: Co-delivery of tetrandrine and miRNA-126. International Journal of Biological Macromolecules. 330(Pt 4). 148256–148256.
4.
Belal, Tarek S., et al.. (2024). Qualitative and quantitative analysis of some tramadol registered and illegitimate dosage forms in Egypt. 1(1). 11–21. 1 indexed citations
5.
Tekko, Ismaiel A., Ahlam Ali, Alyaa A. Ramadan, et al.. (2022). Hollow microneedle assisted intradermal delivery of hypericin lipid nanocapsules with light enabled photodynamic therapy against skin cancer. Journal of Controlled Release. 348. 849–869. 78 indexed citations
6.
El‐Moslemany, Riham M., et al.. (2022). Itraconazole for Topical Treatment of Skin Carcinogenesis: Efficacy Enhancement by Lipid Nanocapsule Formulations. Journal of Biomedical Nanotechnology. 18(1). 97–111. 7 indexed citations
7.
El‐Kamel, Amal H., et al.. (2021). Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis. International Journal of Nanomedicine. Volume 16. 8013–8033. 21 indexed citations
8.
El‐Moslemany, Riham M., et al.. (2021). Enhancing the in vitro and in vivo activity of itraconazole against breast cancer using miltefosine-modified lipid nanocapsules. Drug Delivery. 28(1). 906–919. 25 indexed citations
9.
Ramadan, Alyaa A., et al.. (2020). Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics. International Journal of Pharmaceutics. 586. 119598–119598. 54 indexed citations
10.
Ramadan, Alyaa A., et al.. (2019). Community pharmacists’ perceptions, awareness and practices regarding counterfeit medicines: a cross-sectional survey in Alexandria, Egypt. Eastern Mediterranean Health Journal. 26(5). 556–564. 21 indexed citations
11.
Ramadan, Alyaa A., et al.. (2019). Itraconazole lipid nanocapsules gel for dermatological applications: In vitro characteristics and treatment of induced cutaneous candidiasis. Colloids and Surfaces B Biointerfaces. 181. 623–631. 42 indexed citations
12.
Ramadan, Alyaa A., et al.. (2018). Acyclovir lipid nanocapsules gel for oromucosal delivery: A preclinical evidence of efficacy in the chicken pouch membrane model. European Journal of Pharmaceutical Sciences. 121. 228–235. 15 indexed citations
13.
Saulnier, Patrick, Alyaa A. Ramadan, Viviane Cassisa, et al.. (2018). Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. PLoS ONE. 13(1). e0189950–e0189950. 73 indexed citations
14.
Ramadan, Alyaa A., et al.. (2018). Praziquantel&ndash;lipid nanocapsules: an oral nanotherapeutic with potential <em>Schistosoma mansoni</em> tegumental targeting. International Journal of Nanomedicine. Volume 13. 4493–4505. 41 indexed citations
15.
Ramadan, Alyaa A., et al.. (2017). Entrapment efficiency of pyridoxine hydrochloride in unilamellar liposomes: experimental versus model-generated data. Journal of Liposome Research. 28(2). 112–116. 21 indexed citations
16.
El‐Moslemany, Riham M., Maha M. Eissa, Alyaa A. Ramadan, Labiba K. El‐Khordagui, & Mervat Z. El‐Azzouni. (2016). Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni. Acta Tropica. 159. 142–148. 33 indexed citations
17.
Eissa, Maha M., Riham M. El‐Moslemany, Alyaa A. Ramadan, et al.. (2015). Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study. PLoS ONE. 10(11). e0141788–e0141788. 70 indexed citations
18.
Nafee, Noha, et al.. (2015). Liposomal buccal mucoadhesive film for improved delivery and permeation of water-soluble vitamins. International Journal of Pharmaceutics. 488(1-2). 78–85. 84 indexed citations
19.
Atef, M., et al.. (2009). Effect of Albendazole Administration on Pharmacokinetic Aspects of Tylosin in Lactating Goats. Drug Metabolism Letters. 3(3). 137–143. 5 indexed citations
20.
Ramadan, Alyaa A., et al.. (2005). Surface treatment: A potential approach for enhancement of solid-state photostability. International Journal of Pharmaceutics. 307(2). 141–149. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026